NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-104-2020-0-CA-04 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS CA National Stage 3178538 Pending
NCI E-007-2019-0-CA-03 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER CA National Stage 3119736 Issued
NIAID E-139-2006-0-AU-70 Development Of Dengue Virus Vaccine Components AU DIV 2021202950 Issued
NCI E-241-2016-0-US-07 RADIOACTIVE SOURCE CALIBRATION US CON 17/314,355 11614548 Issued PDF
NIAID E-251-2020-0-PCT-02 PPMO Targeting SARS-CoV-2 Genomic RNA To Treat And Prevent Coronavirus Infection PCT PCT PCT/US2020/031335 Expired
NCI E-101-2021-0-US-01 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 US 63/185,805 Abandoned
NINDS E-120-2020-1-US-01 ADAPTABLE DUAL-TUNED ON-COIL RF POWER AMPLIFIER BY AUTOMATED TUNING OF FET DRIVER CIRCUIT US 63/185,219 Abandoned
NCI E-105-2021-0-US-01 COUMARIN LUCIFERINS FOR BIOLUMINESCENCE IMAGING US 63/184,432 Abandoned
NIAID E-128-2016-0-US-06 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONAVIRUSES US CON 17/307,066 Pending
NICHD E-226-2010-0-US-05 MRI TRACTOGRAPHY BASED TRANSIT TIME DETERMINATION FOR NERVE FIBERS US CON 17/306,841 Pending
NCI E-053-2015-1-US-11 MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE US CON 17/306,756 Abandoned
NLM E-110-2016-3-US-02 Novel CRISPR Enzymes And Systems US CON 17/246,460 Pending
NCI E-097-2018-0-HK-19 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES HK EP 62021030236.5 Pending
NLM E-110-2016-3-US-03 Novel CRISPR Enzymes And Systems US CON 17/246,466 Pending
NIDCR E-150-2019-0-PCT-02 Application Of AAV44.9 Vector In Gene Therapy For The Inner Ear PCT PCT PCT/US2021/030055 Expired
NIAID E-131-2019-0-PCT-02 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE PCT PCT PCT/US2021/029988 Expired
NIAID E-131-2019-0-CN-03 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE CN National Stage 202180046741.1 Pending
NIAID E-131-2019-0-EP-04 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE EP National Stage 21726787.1 Pending
NIAID E-131-2019-0-IN-05 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE IN National Stage 202217065780 Pending
NIDA E-122-2022-0-US-01 ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS US 63/181,826 Abandoned
NHLBI E-123-2022-0-US-01 System And Method For Spiral-in-out BSSFP Real-time Cine On A High Performance 0.55T Scanner US 63/181,537 Abandoned
NCI E-099-2021-0-US-01 LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE US 63/181,519 Abandoned
NIAID E-038-2017-1-US-04 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US CON 17/243,455 11760794 Issued PDF
NCI E-085-2013-0-AU-30 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood AU DIV 2021202640 Issued
NCI E-229-2014-0-JP-12 METHODS FOR ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR CANCER SPECIFIC MUTATIONS JP DIV 2021-076293 Issued
NIDDK E-126-2021-0-US-01 PURINE NUCLEOSIDES, THEIR INTERMEDIATES, AND METHODS OF PREPARATION THEREOF US 63/180,872 Abandoned
NHLBI E-142-2021-0-US-01 System And Method For Maxwell Compensation For Spiral Turbo-Spin-Echo Imaging US 63/180,807 Abandoned
NCI E-125-2021-0-US-02 Methods And Materials For Large-Scale Assessment Of Ligand Binding Selectivity Of G-Quadruplex Recognition Using Custom G4 Microarrays US ORD 17/241,912 Abandoned
NIAID E-166-2021-2-US-01 Coronavirus Antibodies And Uses Thereof US 63/180,564 Abandoned
NIAID E-239-2020-0-US-01 Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing SARS-COV-2 Spike Protein and Its Use US 63/180,534 Abandoned
NCI E-520-2013-0-US-02 Identification And Characterization Of HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein US DIV 17/240,260 11732017 Issued PDF
NIAID E-221-2022-0-US-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME US 63/179,993 Expired
NIAID E-221-2022-1-US-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF SICKLE CELL DISEASE US 63/180,001 Expired
NCI E-078-2012-0-CA-11 Anti-Mesothelin Chimeric Antigen Receptors CA DIV 3116051 Issued
NCATS E-091-2016-0-US-08 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE US CON 17/237,351 11753408 Issued PDF
NIA E-062-2021-0-US-01 HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE US 63/178,083 Abandoned
NCI E-176-2014-0-IL-60 Anti-Human Papillomavirus 16 E7 T Cell Receptors IL DIV 282518 Issued
NCI E-191-2019-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH
Q61K MUTATION 		US 63/177,570 Abandoned
NCI E-166-2018-0-AU-05 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS AU National Stage 2019364436 Issued
NHGRI E-054-2020-0-PCT-02 ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS PCT PCT PCT/US2021/028228 Expired
NCATS E-026-2016-0-TW-23 Compounds for Improving mRNA Splicing TW DIV 110113924 Pending
NIAID E-216-2018-2-US-02 MULTISPECIFIC ANTI-HIV ANTIBODIES US National Stage 17/285,956 Pending
NLM E-107-2010-2-US-33 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/231,671 11208683 Issued PDF
NIDDK E-108-2020-0-PCT-02 Thyclotides PCT PCT PCT/US2021/027397 Expired
NCI E-166-2018-0-CA-06 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CA National Stage 3116749 Issued
NIAID E-100-2021-0-US-01 PRE-BIOTIC FORMULATION OF TOPICAL CHEMICALS FOR USE ON SKIN US 63/175,368 Abandoned
NCI E-176-2014-0-CN-59 Anti-Human Papillomavirus 16 E7 T Cell Receptors CN DIV 202110399056.9 Issued
NCI E-160-2018-0-US-06 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION US National Stage 17/285,453 Pending
NCI E-229-2014-0-AU-11 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation AU DIV 2021202223 Issued
NCI E-266-2011-0-CA-59 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage CA DIV 3114877 Issued